AbbVie Inc $55.67

down -0.08


27/8/2014 11:00 AM  |  NYSE : ABBV  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ABBV Trend Analysis - it has outperformed the S&P 500 by 8%

Partner Headlines

  1. IRS, Eh? Tim Hortons Deal Could Lower Burger King's Tax Bill

    FoxBusiness
  2. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD
  3. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  4. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  5. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga
  6. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD
  7. Markets Little Changed As Ukraine Uncertainty And Fears Persist

    Benzinga
  8. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  9. #PreMarket Primer: Wednesday, August 6: Sprint Prepares To Go It Alone

    Benzinga
  10. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD
  11. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  12. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  13. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  14. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  15. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD
  16. The Stocks Already in Correction Mode

    FoxBusiness
  17. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  18. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD
  19. UPDATE: UBS Upgrades AbbVie

    Benzinga
  20. AbbVie Beats Earnings Views, Sees Slower Humira Gain

    IBD
  21. #PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth

    Benzinga
  22. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  23. Benzinga's Weekend M&A Chatter

    Benzinga
  24. AbbVie Clinches Shire Deal

    IBD
  25. Investors Focus On Earnings Rather Than Geopolitical Tensions

    Benzinga
  26. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  27. AbbVie Buys Shire For $54 Billion

    IBD
  28. Stocks Futures Up On Q2 Reports; Abbvie-Shire, Google Positive

    IBD
  29. Benzinga's Top #PreMarket Losers

    Benzinga
  30. AbbVie to Acquire Shire for £24.44 in Cash and 0.8960 New AbbVie Shares

    Benzinga
  31. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  32. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  33. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  34. Bank Of America Boosts AbbVie PT On Increased Likelihood Of Deal

    Benzinga
  35. Irish Stocks Come To Prominence As Taxes Stay Low

    IBD
  36. AbbVie Near $54 Bil Shire Buy

    IBD
  37. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  38. Dow Sets New Intraday High; Citigroup Impresses With Earnings

    Benzinga
  39. Stocks On Pace For Second Gain; Kandi Keeps Soaring

    IBD
  40. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  41. Can Investors Profit From Friday's Rumors? Depends Who You Ask

    Benzinga
  42. Benzinga's Top #PreMarket Losers

    Benzinga
  43. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  44. Benzinga's Weekend M&A Chatter

    Benzinga
  45. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  46. Markets Close Higher Ahead Of Busy Earnings Season

    Benzinga
  47. Shire Shares Volatile Surrounding Speculation And Confirmation Of AbbVie ...

    Benzinga
  48. Stocks Trade Around Flat Line; Harman Clears Buy Point

    IBD
  49. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD
  50. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
Trading Center